Anaelle dos santos bioanalytics unit, novimmune sa
Answers
Answered by
26
Hai
Geneva, Switzerland – 18th July, 2017 – Novimmune a privately held, Swiss biopharmaceutical company focused on the discovery and development of innovative antibody-based medicines, and Shire, the biotech leader in Rare Diseases, today announced they have entered into an agreement, granting Shire exclusive worldwide rights to develop and commercialize an innovative, bi-specific antibody in pre-clinical development for the treatment of hemophilia A. Novimmune is creating and optimizing a fully human, bi-specific IgG antibody targeting FIXa and FX, designed to imitate the body’s natural mechanism of Factor VIII driven coagulation. Shire’s ultimate aim is to deliver a treatment that is highly efficacious with fewer side effects that improves upon the strong and long-term record of efficacy and safety that has been set by the class of clotting factor treatments
I hope it's help you
Geneva, Switzerland – 18th July, 2017 – Novimmune a privately held, Swiss biopharmaceutical company focused on the discovery and development of innovative antibody-based medicines, and Shire, the biotech leader in Rare Diseases, today announced they have entered into an agreement, granting Shire exclusive worldwide rights to develop and commercialize an innovative, bi-specific antibody in pre-clinical development for the treatment of hemophilia A. Novimmune is creating and optimizing a fully human, bi-specific IgG antibody targeting FIXa and FX, designed to imitate the body’s natural mechanism of Factor VIII driven coagulation. Shire’s ultimate aim is to deliver a treatment that is highly efficacious with fewer side effects that improves upon the strong and long-term record of efficacy and safety that has been set by the class of clotting factor treatments
I hope it's help you
Answered by
6
Dear user
Please ask questions in a liable way otherwise we can't understand what it is
Please ask questions in a liable way otherwise we can't understand what it is
Similar questions